Aastrom Biosciences (ASTMD)
Aastrom Biosciences EBITDA Margin TTM
View ASTMD EBITDA Margin TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
About EBITDA Margin (TTM)
The EBITDA Margin is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.
Investors look at this measurement to get a closer approximation of performance of the business relative to sales before adjusting for the capital structure of the business (debt vs. equity financing).
Though many investors use EBITDA for this reason, some argue that the exclusion of depreciation expenses fails to capture the ongoing economics of a business since depreciation expenses are a good proxy for the replacement costs of property, plant and equipment, which must be paid in the future to continue business operations.
Learn More
You may also be interested in these ASTMD related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ASTMD | 2.05 | -0.01 | -0.49% | |
| ASTM | 2.05 | -0.01 | -0.49% | 79.46M |
| ASTI | 0.5391 | -0.02 | -3.73% | 22.08M |
| ASTE | 28.39 | -0.11 | -0.39% | 644.74M |
| BBOX | 22.22 | +0.19 | +0.86% | 388.41M |
| BBNK | 15.01 | +0.03 | +0.20% | 227.70M |
| BBL | 53.22 | -0.73 | -1.35% | 56.90B |
| BBH | 46.16 | +0.28 | +0.61% | |
| BBGI | 5.76 | +0.00 | +0.00% | 130.98M |
| BBG | 20.65 | +0.31 | +1.52% | 987.90M |
